These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 8405092)

  • 41. Lack of robust anticonvulsant effects of muscimol microinfusions in the anterior substantia nigra of kindled rats.
    Gernert M; Löscher W
    Eur J Pharmacol; 2001 Nov; 432(1):35-41. PubMed ID: 11734185
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Dextromethorphan: cellular effects reducing neuronal hyperactivity.
    Trube G; Netzer R
    Epilepsia; 1994; 35 Suppl 5():S62-7. PubMed ID: 7518769
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Competitive NMDA receptor antagonists raise electrically kindled generalized seizure thresholds.
    Croucher MJ; Cotterell KL; Bradford HF
    Neurochem Res; 1992 May; 17(5):409-13. PubMed ID: 1356242
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Evidence for a unique profile of levetiracetam in rodent models of seizures and epilepsy.
    Klitgaard H; Matagne A; Gobert J; Wülfert E
    Eur J Pharmacol; 1998 Jul; 353(2-3):191-206. PubMed ID: 9726649
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Induction of phencyclidine-like behavior in rats by dextrorphan but not dextromethorphan.
    Székely JI; Sharpe LG; Jaffe JH
    Pharmacol Biochem Behav; 1991 Oct; 40(2):381-6. PubMed ID: 1805242
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Anticonvulsant properties of non-competitive antagonists of the N-methyl-D-aspartate receptor in genetically epilepsy-prone rats: comparison with CPPene.
    De Sarro GB; De Sarro A
    Neuropharmacology; 1993 Jan; 32(1):51-8. PubMed ID: 8094234
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Weak anticonvulsant effects of two novel glycineB receptor antagonists in the amygdala-kindling model in rats.
    Wlaź P; Löscher W
    Eur J Pharmacol; 1998 Jan; 342(1):39-46. PubMed ID: 9544790
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Comparison of the effects of dextromethorphan, dextrorphan, and levorphanol on the hypothalamo-pituitary-adrenal axis.
    Pechnick RN; Poland RE
    J Pharmacol Exp Ther; 2004 May; 309(2):515-22. PubMed ID: 14742749
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Glutamate receptor antagonists differentially affect the protective activity of conventional antiepileptics against amygdala-kindled seizures in rats.
    Borowicz KK; Kleinrok Z; Czuczwar SJ
    Eur Neuropsychopharmacol; 2001 Feb; 11(1):61-8. PubMed ID: 11226813
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The anticonvulsant effects of allopregnanolone against amygdala-kindled seizures in female rats.
    Lonsdale D; Burnham WM
    Neurosci Lett; 2007 Jan; 411(2):147-51. PubMed ID: 17084970
    [TBL] [Abstract][Full Text] [Related]  

  • 51. N-methyl-D-aspartate (NMDA) antagonists--S(+)-ketamine, dextrorphan, and dextromethorphan--act as calcium antagonists on bovine cerebral arteries.
    Kamel IR; Wendling WW; Chen D; Wendling KS; Harakal C; Carlsson C
    J Neurosurg Anesthesiol; 2008 Oct; 20(4):241-8. PubMed ID: 18812887
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The anti-epileptic effect of 3-aminopropylarsonate on electrically-kindled and N-methyl-D-aspartate-kindled amygdala.
    Abdul-Ghani AS; Attwell PJ; Bradford HF
    Brain Res; 1996 Dec; 742(1-2):305-12. PubMed ID: 9117409
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Behavioural pharmacology of the non-competitive NMDA antagonists dextrorphan and ADCI: relations between locomotor stimulation, anticataleptic potential and forebrain dopamine metabolism.
    Bubser M; Zadow B; Kronthaler UO; Felsheim U; Rückert NG; Schmidt WJ
    Naunyn Schmiedebergs Arch Pharmacol; 1997 Jun; 355(6):767-73. PubMed ID: 9205962
    [TBL] [Abstract][Full Text] [Related]  

  • 54. LU 73068, a new non-NMDA and glycine/NMDA receptor antagonist: pharmacological characterization and comparison with NBQX and L-701,324 in the kindling model of epilepsy.
    Potschka H; Löscher W; Wlaź P; Behl B; Hofmann HP; Treiber HJ; Szabo L
    Br J Pharmacol; 1998 Nov; 125(6):1258-66. PubMed ID: 9863655
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The effects of N-methyl-D-aspartate (NMDA) and its competitive antagonist, 3-(2-carboxypiperazine-4-yl)propyl-1-phosphonic acid (CPP), injected into caudate-putamen on kindled amygdaloid seizures in rats.
    Osonoe M; Mori N; Hoshino S; Yamada Y; Osonoe K; Kittaka H; Iwata Y
    Brain Res; 1996 Jul; 728(2):242-6. PubMed ID: 8864488
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Evaluation of CPP, a selective NMDA antagonist, in various rodent models of epilepsy. Comparison with other NMDA antagonists, and with diazepam and phenobarbital.
    Löscher W; Nolting B; Hönack D
    Eur J Pharmacol; 1988 Jul; 152(1-2):9-17. PubMed ID: 3061831
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Antiepileptogenic and anticonvulsant effects of NBQX, a selective AMPA receptor antagonist, in the rat kindling model of epilepsy.
    Namba T; Morimoto K; Sato K; Yamada N; Kuroda S
    Brain Res; 1994 Feb; 638(1-2):36-44. PubMed ID: 8199874
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Pharmacokinetics, anticonvulsant efficacy, and adverse effects of trans-2-en-valproate after acute and chronic administration in amygdala-kindled rats.
    Hönack D; Rundfeldt C; Löscher W
    Naunyn Schmiedebergs Arch Pharmacol; 1992 Feb; 345(2):187-96. PubMed ID: 1570023
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effects of the non-NMDA antagonists NBQX and the 2,3-benzodiazepine GYKI 52466 on different seizure types in mice: comparison with diazepam and interactions with flumazenil.
    Löscher W; Hönack D
    Br J Pharmacol; 1994 Dec; 113(4):1349-57. PubMed ID: 7889291
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The protective effect of 2-chloroadenosine against the development of amygdala kindling and on amygdala-kindled seizures.
    Abdul-Ghani AS; Attwell PJ; Bradford HF
    Eur J Pharmacol; 1997 May; 326(1):7-14. PubMed ID: 9178649
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.